
|Articles|June 28, 2023
Making the Case for Case Management for Cell and Gene Therapies
Author(s)Catalent
This infographic highlights variables for supply chain oversight and management for cell and gene therapies, which should be considered early - before the finished therapy is ready for patient administration.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
FDA Launches PreCheck Pilot Program to Bolster Domestic Drug Manufacturing
2
Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D
3
Cellares Scales IDMO Model for Gene-Edited Stem Cells Therapies
4
Women in STEM: Cultivating Scientific Confidence
5